Arecor Therapeutics Revenue

In the year 2024, Arecor Therapeutics had annual revenue of 5.05M GBP with 10.50% growth. Arecor Therapeutics had revenue of 3.06M in the half year ending December 31, 2024, with 78.83% growth.

Revenue

5.05M

Revenue Growth

+10.50%

P/S Ratio

3.66

Revenue / Employee

114.84K

Employees

Market Cap

18.50M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	5.05M	480.00K	10.50%
Dec 31, 2023	4.57M	2.17M	90.30%
Dec 31, 2022	2.40M	1.25M	107.51%
Dec 31, 2021	1.16M	-540.00K	-31.80%
Dec 31, 2020	1.70M	-192.99K	-10.21%
Dec 31, 2019	Pro	Pro	Pro
May 31, 2019	Pro	Pro	Pro
May 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
AstraZeneca	42.56B
GSK plc	31.53B
Haleon	11.23B
Smith & Nephew	4.64B
ConvaTec Group	1.83B
Hikma Pharmaceuticals	2.50B
HUTCHMED (China)	503.39M
Genus	671.60M

Revenue Rankings

Arecor Therapeutics News

12 days ago - Skye Bioscience Partners With Arecor: Potentially Enhanced Nimacimab Dosing - Seeking Alpha
2 months ago - AIM Market Roundup: The Revel Collective, Tanfield, Arecor - The Armchair Trader
2 months ago - Full Year 2024 Arecor Therapeutics PLC Earnings Presentation (Shareholder Q&A) Transcript - GuruFocus
10 months ago - Half Year 2024 Arecor Therapeutics PLC Earnings Presentation Transcript - GuruFocus

More News